COPD

February 7, 2018February 7, 2018

Remote Monitoring Could Help COPD Patients, but More Studies Needed, Researchers Conclude

COPD, News

Devices that remotely monitor COPD patients’ conditions could help improve their outcomes, a study suggests. A Cedars-Sinai Medical Center team said there were signs in the previous research it analyzed that ... Read more

January 29, 2018January 29, 2018

COPD Care at Home Rather Than Hospital Boosts Patient Outcomes, Canadian Study Finds

COPD, News

Moving chronic obstructive pulmonary disease (COPD) patients from hospitals to their homes could improve the sustainability of Canada’s health system while improving individual outcomes, says the Canadian Foundation for Healthcare Improvement ... Read more

November 27, 2017November 27, 2017

New York’s Montefiore Einstein Center Launches Lung Transplant Program

COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, News

New York City’s Montefiore Einstein Center for Heart & Vascular Care has received interim approval from the United Network for Organ Sharing (UNOS) to launch its new lung transplant program. Lung transplant ... Read more

September 15, 2017September 15, 2017

Identification of Regenerative and Scar-Forming Cells May Lead to New Lung Therapies, Study Reports

COPD, Idiopathic Pulmonary Fibrosis, News

Researchers have identified two types of lung cells, one with regenerative features and the other with scar-forming characteristics, according to a study published in the journal Cell. The research team ... Read more

September 11, 2017September 11, 2017

Study Links Fungus Antibodies with Development of Bronchiectasis in COPD Patients

Bronchiectasis, COPD, News

Researchers have linked the presence of antibodies against the Aspergillus fumigatus (A fum) fungus with the development of bronchiectasis in people with COPD. The study, “Sensitization to Aspergillus fumigatus as a risk factor ... Read more

August 29, 2017August 29, 2017

Three Share British Lung Foundation Grant for Lung Disease Research

Bronchiectasis, COPD, Idiopathic Pulmonary Fibrosis, News

Toby Maher, MD, a professor at Imperial College London and based at the National Heart and Lung Institute, is one of three researchers who were awarded the prestigious Chair in Respiratory Research grant ... Read more

August 24, 2017August 25, 2017

Ethris, AstraZeneca and MedImmune to Collaborate on Developing Respiratory Disease Therapies

Asthma, COPD, Idiopathic Pulmonary Fibrosis, News

Ethris has entered into a five-year research partnership with AstraZeneca and its subsidiary MedImmune to develop mRNA-based therapies for lung diseases. The partnership will use Ethris’ proprietary SNIM®RNA technology. The nucleic acid ... Read more

August 22, 2017August 29, 2017

North Carolina Advances in Stem Cell Therapy for Lung Diseases Could Lead to Clinical Trial Soon

COPD, Cystic Fibrosis, Idiopathic Pulmonary Fibrosis, News

University of North Carolina Health Care researchers have made strides toward a stem cell treatment for lung diseases such as pulmonary fibrosis, COPD, and cystic fibrosis. In fact, they are discussing ... Read more

August 18, 2017August 18, 2017

Vaccination Against Lung Pathogens Vital for People with Lung Disease, American Lung Association Reminds

Asthma, COPD, News, Pneumonia

August is National Immunization Awareness Month, and the American Lung Association is reminding adults with serious lung diseases that the Centers for Disease Control and Prevention (CDC) recommends vaccination against common ... Read more

July 31, 2017July 31, 2017

Revefenacin May Be Potential Treatment for COPD Patients, Phase 3 Clinical Trial Shows

COPD, News

Treatment with revefenacin (TD-4208) has shown promise in a Phase 3 clinical trial (NCT02518139) with chronic obstructive pulmonary disease (COPD) patients, said Theravance Biopharma and Mylan. Revefenacin is an investigational long-acting ... Read more